Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VI.

Although these improvements in bone length from the combined treatment were consistently observed, they were more prominent in male animals and did not reach statistical significance when all of the treated mice (male and female) were grouped together.

also in 111,027 other papers